Evidence from tested commercial products indicates that Moderna's LNPs fall under Genevant and Arbutus's patents. The actions expand on an ongoing case in the U.S. regarding similar infringement ...
Sun, 09 Mar 2025 05:55:04 GMT (Reuters) - Arbutus Biopharma Corp said on Monday it had filed a lawsuit against Moderna Inc seeking damages for infringement of patents related to its COVID-19 vaccine.
Before that, Moderna (NYSE: MRNA) had filed a patent infringement lawsuit against ... Pennsylvania firm Arbutus Biopharma Corp. (Nasdaq: ABUS) and its affiliate Genevant Sciences filed a lawsuit ...
Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...
Genevant Sciences and Arbutus Biopharma (ABUS) filed five international lawsuits seeking to enforce patents protecting their innovative LNP ...
which upon later choice of Genevant and Arbutus can include surrender of profits, damages or a reasonable royalty, for infringement of EP 2 279 254. Unified Patent Court (UPC): Case 10280/2025 ...
Switzerland: filing a case seeking a permanent injunction and monetary relief, which upon later choice of Genevant and Arbutus can include surrender of profits, damages or a reasonable royalty, for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results